Packing the massive sensor of the Ursa Cine 12K into a modular body, the Pyxis 12K offers industry-leading resolution, though ...

Having recently trimmed back its pipeline to a sole cancer candidate, Pyxis Oncology has now reduced its head count to match. The Boston biotech is shrinking its workforce by "approximately" 20%, it ...

Pyxis Oncology is slimming down after a tough start to life on public markets, pausing work on two assets and stopping development of a third altogether to focus its cash on getting its lead programs ...

A new and astonishing development has been revealed as the Pyxis Ocean has been testing the WindWing system, which provides ...

Lara Sullivan, Pyxis Oncology CEO, joins Yahoo Finance to discuss the biotech company going public and its oncology treatments for patients with difficult-to-treat cancer. JARED BLIKRE: Well, an IPO ...

BOSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today ...

Advanced digital film camera in a versatile design with revolutionary full frame 12K RGBW sensor in EF, PL or L-Mount, Blackmagic RAW and global media sync with Blackmagic Cloud! Blackmagic PYXIS 12K ...

Pyxis Oncology (NASDAQ:PYXS) shares reached a new 52-week high as the clinical-stage biotech backed by pharma giant Pfizer (PFE) extended the recent winning streak into the fifth consecutive session, ...

Antibody drug conjugates, or ADCs, are picking up momentum. Of the 11 drugs in this class that have been approved by the FDA, six have reached the market in the last two years. Meanwhile, new ADC ...